Swine-Flu: Which Stock Will Break Out?

NEW YORK (TheStreet) -- There's been tremendous hype and speculation regarding which companies -- and which stocks -- might "benefit" from a vicious return of the swine flu this fall.

The crassness of the sentiment aside, investors have looked long and hard at everything from vaccine makers to drug-store chains to hospital operators to (on the short side) travel-related outfits such as airlines and cruise ships.

The gamut of companies has ranged from the big (Gilead(GILD Quote), licensee of Tamiflu; Walgreen(WAG Quote), the pharmacist) to the medium (Inverness Medical Innovations(IMA Quote), the maker of diagnostic instruments) to the small (Sinovac(SVA Quote), the Chinese vaccine maker that scored China's swine-flu pandemic contract).

Which lead us to the inevitable, if indelicate, question: Which stock is poised to advance as flu season commences in earnest this month?

Which swine flu-related stock is poised to break out as swine-flu season approaches?
	Gilead Walgreen Inverness Medical Innovations Sinovac